US Stock MarketDetailed Quotes

TMCI Treace Medical Concepts

Watchlist

6.420
+0.220+3.55%

Close Aug 23 16:00 ET

6.420
0.0000.00%

Post 17:30 ET

399.26MMarket Cap-6294P/E (TTM)

Treace Medical Concepts Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-66.73%-13.9M

58.16%-7.22M

-12.81%-34.58M

109.93%532K

-27.13%-9.51M

21.11%-8.34M

-138.35%-17.26M

-78.26%-30.65M

-42.80%-5.36M

19.22%-7.48M

Net income from continuing operations

-72.81%-21.21M

-38.81%-18.68M

-15.68%-49.53M

-42.36%-6.28M

-44.41%-17.52M

28.80%-12.27M

-48.89%-13.45M

-108.33%-42.82M

33.34%-4.41M

-89.05%-12.13M

Operating gains losses

----

6,086.11%4.31M

--0

Depreciation and amortization

93.24%2.12M

106.60%1.91M

150.91%5.35M

92.91%1.77M

240.74%1.56M

158.87%1.1M

176.65%924K

211.39%2.13M

232.25%917K

142.86%459K

Other non cash items

-0.95%733K

11.82%757K

6.16%2.96M

20.61%708K

-11.23%838K

-15.81%740K

77.69%677K

1,485.80%2.79M

1,265.12%587K

1,997.78%944K

Change In working capital

-240.29%-3.98M

119.86%1.56M

-67.72%-9.74M

73.84%-1.52M

-20.31%781K

-61.24%-1.17M

-2,814.13%-7.84M

-490.95%-5.81M

-569.61%-5.8M

124.79%980K

-Change in receivables

229.84%2.48M

106.20%7.82M

15.74%-9.3M

-20.95%-13.42M

208.81%2.24M

-343.49%-1.91M

49.21%3.79M

-161.22%-11.04M

-59.14%-11.1M

-16.44%-2.05M

-Change in inventory

-54.17%-5.42M

-107.43%-6.62M

-12.30%-9.85M

102.44%67K

11.22%-3.21M

-89.08%-3.52M

-478.77%-3.19M

-219.92%-8.77M

-8,745.16%-2.74M

-29.22%-3.62M

-Change in prepaid assets

347.79%1.68M

-55.24%-1.5M

-81.14%-1.21M

-146.67%-182K

3,326.32%613K

70.16%-678K

-178.10%-963K

72.36%-668K

-48.07%390K

92.37%-19K

-Change in payables and accrued expense

-163.69%-2.1M

134.44%2.4M

-8.88%10.7M

64.33%12.64M

-71.20%1.72M

151.64%3.3M

-115.69%-6.96M

39.71%11.74M

2.71%7.69M

594.87%5.96M

-Change in other current assets

----

--0

----

48.51%-69K

---146K

--0

---12K

-Change in other current liabilities

-140.90%-634K

-37.45%-657K

-103.87%-119K

-1,611.11%-616K

-179.86%-575K

-38.61%1.55M

-259.40%-478K

--3.08M

---36K

--720K

-Change in other working capital

53.85%20K

328.00%107K

--40K

--0

--2K

--13K

--25K

----

Cash from discontinued investing activities

Operating cash flow

-66.73%-13.9M

58.16%-7.22M

-12.81%-34.58M

109.93%532K

-27.13%-9.51M

21.11%-8.34M

-138.35%-17.26M

-78.26%-30.65M

-42.80%-5.36M

19.22%-7.48M

Investing cash flow

Cash flow from continuing investing activities

315.23%22.43M

104.67%3.76M

-6.25%-81.3M

107.82%5.01M

178.49%4.6M

-101.68%-10.42M

-5,334.17%-80.48M

-2,728.76%-76.52M

-7,012.44%-64.01M

-523.75%-5.86M

Net PPE purchase and sale

59.13%-1.73M

-165.70%-3.93M

22.78%-11.46M

3.60%-2.25M

40.23%-3.5M

18.13%-4.23M

0.20%-1.48M

-448.54%-14.84M

-159.11%-2.33M

-523.75%-5.86M

Net business purchase and sale

----

---20M

--0

----

--0

Net investment purchase and sale

74.99%24.16M

109.73%7.69M

19.19%-49.84M

111.76%7.26M

--8.1M

--13.81M

---79M

---61.68M

--0

Cash from discontinued investing activities

Investing cash flow

315.23%22.43M

104.67%3.76M

-6.25%-81.3M

107.82%5.01M

178.49%4.6M

-101.68%-10.42M

-5,334.17%-80.48M

-2,728.76%-76.52M

-7,012.44%-64.01M

-523.75%-5.86M

Financing cash flow

Cash flow from continuing financing activities

-73.64%311K

-100.17%-185K

425.73%109.38M

-44.44%165K

-54.96%159K

-93.72%1.18M

7,762.90%107.88M

-80.67%20.81M

-71.05%297K

760.98%353K

Net issuance payments of debt

----

--0

----

1,196.64%19.61M

--0

Net common stock issuance

--0

--107.53M

--0

--107.53M

--0

Proceeds from stock option exercised by employees

-73.64%311K

-85.23%52K

-15.13%1.86M

-44.44%165K

-54.96%159K

615.15%1.18M

-74.34%352K

19.51%2.19M

-71.05%297K

760.98%353K

Net other financing activities

--0

---237K

----

---989K

--0

Cash from discontinued financing activities

Financing cash flow

-73.64%311K

-100.17%-185K

425.73%109.38M

-44.44%165K

-54.96%159K

-93.72%1.18M

7,762.90%107.88M

-80.67%20.81M

-71.05%297K

760.98%353K

Net cash flow

Beginning cash position

-68.48%9.33M

-33.33%12.98M

-81.60%19.47M

-91.78%7.28M

-88.15%12.04M

-69.93%29.61M

-81.60%19.47M

485.39%105.83M

-19.11%88.55M

-15.12%101.53M

Current changes in cash

150.33%8.85M

-135.98%-3.65M

92.48%-6.49M

108.26%5.7M

63.37%-4.76M

-676.33%-17.58M

237.96%10.14M

-198.41%-86.36M

-1,804.94%-69.07M

-27.80%-12.99M

End cash Position

51.07%18.18M

-68.48%9.33M

-33.33%12.98M

-91.78%7.28M

-88.15%12.04M

-69.93%29.61M

-81.60%19.47M

-19.11%88.55M

Free cash flow

-24.35%-15.63M

40.50%-11.15M

-1.20%-46.03M

77.69%-1.72M

2.44%-13.01M

20.13%-12.57M

-114.82%-18.74M

-128.60%-45.49M

-65.31%-7.69M

-30.75%-13.34M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-66.73%-13.9M	58.16%-7.22M	-12.81%-34.58M	109.93%532K	-27.13%-9.51M	21.11%-8.34M	-138.35%-17.26M	-78.26%-30.65M	-42.80%-5.36M	19.22%-7.48M
Net income from continuing operations	-72.81%-21.21M	-38.81%-18.68M	-15.68%-49.53M	-42.36%-6.28M	-44.41%-17.52M	28.80%-12.27M	-48.89%-13.45M	-108.33%-42.82M	33.34%-4.41M	-89.05%-12.13M
Operating gains losses	----	----	----	----	----	----	----	6,086.11%4.31M	--0	--0
Depreciation and amortization	93.24%2.12M	106.60%1.91M	150.91%5.35M	92.91%1.77M	240.74%1.56M	158.87%1.1M	176.65%924K	211.39%2.13M	232.25%917K	142.86%459K
Other non cash items	-0.95%733K	11.82%757K	6.16%2.96M	20.61%708K	-11.23%838K	-15.81%740K	77.69%677K	1,485.80%2.79M	1,265.12%587K	1,997.78%944K
Change In working capital	-240.29%-3.98M	119.86%1.56M	-67.72%-9.74M	73.84%-1.52M	-20.31%781K	-61.24%-1.17M	-2,814.13%-7.84M	-490.95%-5.81M	-569.61%-5.8M	124.79%980K
-Change in receivables	229.84%2.48M	106.20%7.82M	15.74%-9.3M	-20.95%-13.42M	208.81%2.24M	-343.49%-1.91M	49.21%3.79M	-161.22%-11.04M	-59.14%-11.1M	-16.44%-2.05M
-Change in inventory	-54.17%-5.42M	-107.43%-6.62M	-12.30%-9.85M	102.44%67K	11.22%-3.21M	-89.08%-3.52M	-478.77%-3.19M	-219.92%-8.77M	-8,745.16%-2.74M	-29.22%-3.62M
-Change in prepaid assets	347.79%1.68M	-55.24%-1.5M	-81.14%-1.21M	-146.67%-182K	3,326.32%613K	70.16%-678K	-178.10%-963K	72.36%-668K	-48.07%390K	92.37%-19K
-Change in payables and accrued expense	-163.69%-2.1M	134.44%2.4M	-8.88%10.7M	64.33%12.64M	-71.20%1.72M	151.64%3.3M	-115.69%-6.96M	39.71%11.74M	2.71%7.69M	594.87%5.96M
-Change in other current assets	----	--0	--0	--0	----	----	48.51%-69K	---146K	--0	---12K
-Change in other current liabilities	-140.90%-634K	-37.45%-657K	-103.87%-119K	-1,611.11%-616K	-179.86%-575K	-38.61%1.55M	-259.40%-478K	--3.08M	---36K	--720K
-Change in other working capital	53.85%20K	328.00%107K	--40K	--0	--2K	--13K	--25K	----	----	----
Cash from discontinued investing activities
Operating cash flow	-66.73%-13.9M	58.16%-7.22M	-12.81%-34.58M	109.93%532K	-27.13%-9.51M	21.11%-8.34M	-138.35%-17.26M	-78.26%-30.65M	-42.80%-5.36M	19.22%-7.48M
Investing cash flow
Cash flow from continuing investing activities	315.23%22.43M	104.67%3.76M	-6.25%-81.3M	107.82%5.01M	178.49%4.6M	-101.68%-10.42M	-5,334.17%-80.48M	-2,728.76%-76.52M	-7,012.44%-64.01M	-523.75%-5.86M
Net PPE purchase and sale	59.13%-1.73M	-165.70%-3.93M	22.78%-11.46M	3.60%-2.25M	40.23%-3.5M	18.13%-4.23M	0.20%-1.48M	-448.54%-14.84M	-159.11%-2.33M	-523.75%-5.86M
Net business purchase and sale	----	----	---20M	--0	--0	----	----	--0	--0	--0
Net investment purchase and sale	74.99%24.16M	109.73%7.69M	19.19%-49.84M	111.76%7.26M	--8.1M	--13.81M	---79M	---61.68M	---61.68M	--0
Cash from discontinued investing activities
Investing cash flow	315.23%22.43M	104.67%3.76M	-6.25%-81.3M	107.82%5.01M	178.49%4.6M	-101.68%-10.42M	-5,334.17%-80.48M	-2,728.76%-76.52M	-7,012.44%-64.01M	-523.75%-5.86M
Financing cash flow
Cash flow from continuing financing activities	-73.64%311K	-100.17%-185K	425.73%109.38M	-44.44%165K	-54.96%159K	-93.72%1.18M	7,762.90%107.88M	-80.67%20.81M	-71.05%297K	760.98%353K
Net issuance payments of debt	----	----	--0	--0	----	----	----	1,196.64%19.61M	--0	--0
Net common stock issuance	--0	--0	--107.53M	--0	--0	--0	--107.53M	--0	--0	--0
Proceeds from stock option exercised by employees	-73.64%311K	-85.23%52K	-15.13%1.86M	-44.44%165K	-54.96%159K	615.15%1.18M	-74.34%352K	19.51%2.19M	-71.05%297K	760.98%353K
Net other financing activities	--0	---237K	----	----	----	----	----	---989K	--0	--0
Cash from discontinued financing activities
Financing cash flow	-73.64%311K	-100.17%-185K	425.73%109.38M	-44.44%165K	-54.96%159K	-93.72%1.18M	7,762.90%107.88M	-80.67%20.81M	-71.05%297K	760.98%353K
Net cash flow
Beginning cash position	-68.48%9.33M	-33.33%12.98M	-81.60%19.47M	-91.78%7.28M	-88.15%12.04M	-69.93%29.61M	-81.60%19.47M	485.39%105.83M	-19.11%88.55M	-15.12%101.53M
Current changes in cash	150.33%8.85M	-135.98%-3.65M	92.48%-6.49M	108.26%5.7M	63.37%-4.76M	-676.33%-17.58M	237.96%10.14M	-198.41%-86.36M	-1,804.94%-69.07M	-27.80%-12.99M
End cash Position	51.07%18.18M	-68.48%9.33M	-33.33%12.98M	-33.33%12.98M	-91.78%7.28M	-88.15%12.04M	-69.93%29.61M	-81.60%19.47M	-81.60%19.47M	-19.11%88.55M
Free cash flow	-24.35%-15.63M	40.50%-11.15M	-1.20%-46.03M	77.69%-1.72M	2.44%-13.01M	20.13%-12.57M	-114.82%-18.74M	-128.60%-45.49M	-65.31%-7.69M	-30.75%-13.34M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall